IGC Reports Financial Results for June 30, 2020 Quarter and Prepares for Phase 1 Cannabinoid Clinical Trial for Alzheimer’s Patients August 20, 2020 Read More »
IGC Announces Proposed Settlement of 3 Derivative Lawsuits & Provides Notice to Shareholders May 8, 2020 Read More »
IGC Receives New Patent from U.S. Patent Office to Treat Cachexia and Eating Disorders in Humans and Veterinary Animals March 26, 2020 Read More »
IGC Reports Financial Results for the Quarter Ended December 31st, 2019 February 11, 2020 Read More »
